Inhaled medicines beyond asthma and COPD Part 3
Part 3/3. Biopharm aspects of new modalities including biologics
Sweden has been a strong player in the field of inhaled medicines for several decades, especially regarding medicines for asthma and COPD. This seminar series initiates the discussion around other, poorly treated lung diseases. The third seminar has a focus on biopharm aspects, and covers inhaled delivery to animals, cell and tissue studies and modeling, and bridging from animals to human.
The seminar series is organized by the Swedish Inhalation Network, SwedIN, in collaboration with Apotekarsocieteten and is intended for everyone who has an interest in the pharmaceutics and bio-pharm of lung deliver
Presented by: Rebecca Fransson, AstraZeneca and Karin von Wachenfeldt, Truly Labs
Moderator: Kyrre Thalberg, senior Advisor at Emmace Consulting AB and Adjunct Professor at Lund University
Time and place